Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06689943 · ClinicalTrials.gov registry record · Phase 2
Pain After Strabismus Surgery
A Phase 2 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Not yet
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT06689943 is a Phase 2 study that has not yet begun recruiting, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 80 participants.
The verdict
NCT06689943, a Phase 2 study, has not yet begun recruiting, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
At Ann \& Robert H. Lurie Children's Hospital of Chicago (Lurie Children's), the current practice is to prescribe children with oral Tylenol as needed every 4-6 hours post strabismus surgery. Prescribing Tylenol "as needed" leaves more room for error for parents to be under-dosing their children, which can lead to avoidable pain. This study aims to figure out if children ages 4-12 years old will feel significantly less pain and discomfort when given regimented Tylenol every 6 hours for 48 hours after strabismus surgery (eye muscle surgery) compared to controls whose parents are instructed to give Tylenol every 4-6 hours as needed for 48 hours after surgery. To date, there have been no studies comparing patient outcomes between those taking Tylenol regimen and those receiving Tylenol as needed after pediatric surgery.
Interventions
- DRUG Tylenol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06689943
The ClinicalTrials.gov registry entry for NCT06689943 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tylenol is the first listed.
NCT06689943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06689943 about?
NCT06689943 is a clinical study titled "Pain After Strabismus Surgery". At Ann \& Robert H. Lurie Children's Hospital of Chicago (Lurie Children's), the current practice is to prescribe children with oral Tylenol as needed every 4-6 hours post strabismus surgery. Prescribing Tylenol "as needed" leaves more room for error for parents to be under-dosing their children, wh...
What is the current status of trial NCT06689943?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2025-04-01. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT06689943?
The interventions under investigation include: Tylenol (DRUG).
Who is sponsoring clinical trial NCT06689943?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.